The Measurement Performance of the Parkinson's Disease Activities of Daily Living, Interference, and Dependence Instrument

por Deal, Linda S., Andrae, David A., Myers, Daniela E., Johnson, Nathan, Foster, Brandon, Evans, Christopher J.
Publicado 2022

A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia

por Shorr, Andrew F, Myers, Daniela E, Huang, David B, Nathanson, Brian H, Emons, Matthew F, Kollef, Marin H
Publicado 2013

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis

por Fowler, Joseph, Sugarman, Jeffrey, Sher, Lawrence, Zang, Chuanbo, Werth, John L., Myers, Daniela E., Graham, Daniela, Marfo, Alexander Agyei, Takiya, Liza
Publicado 2023

The economic burden of Parkinson disease among Medicare beneficiaries

por Albarmawi, Husam, Zhou, Shujia, Shulman, Lisa M, Gandhi, Aakash Bipin, Johnson, Abree, Myers, Daniela E, Gray, David, Alvir, Jose, Onukwugha, Eberechukwu
Publicado 2022

Relationship Among Treatment, Pruritus, Investigator’s Static Global Assessment, and Quality of Life in Patients with Atopic Dermatitis

por Simpson, Eric L., Tom, Wynnis L., Bushmakin, Andrew G., Cappelleri, Joseph C., Yosipovitch, Gil, Ständer, Sonja, Luger, Thomas, Sanders, Paul, Gerber, Robert A., Myers, Daniela E.
Publicado 2021

Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis

por Wu, Jashin J., Lafeuille, Marie-Hélène, Emond, Bruno, Fakih, Iman, Duh, Mei Sheng, Cappelleri, Joseph C., Yin, Natalie, Feeney, Claire, Myers, Daniela E., DiBonaventura, Marco
Publicado 2022

Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study

por Eichenfield, Lawrence F., Gower, Richard G., Xu, JinHua, Alam, Maryam S., Su, John C., Myers, Daniela E., Sanders, Paul, Vlahos, Bonnie, Zang, Chuanbo, Lan, Jar, Werth, John
Publicado 2023

Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Pa...

por Silverberg, Jonathan I., Thyssen, Jacob P., Simpson, Eric L., Yosipovitch, Gil, Ständer, Sonja, Valdez, Hernan, Rojo, Ricardo, Biswas, Pinaki, Myers, Daniela E., Feeney, Claire, DiBonaventura, Marco
Publicado 2021

Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild‐to‐moderate atopic...

por Eichenfield, Lawrence F., Yosipovitch, Gil, Stein Gold, Linda F., Kalabis, Mizuho, Zang, Chuanbo, Vlahos, Bonnie, Sanders, Paul, Myers, Daniela E., Bushmakin, Andrew G., Cappelleri, Joseph C., Olivadoti, Melissa, Paller, Amy S.
Publicado 2020

Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE

por Gooderham, Melinda J., Chu, Chia-Yu, Rojo, Ricardo, Valdez, Hernan, Biswas, Pinaki, Cameron, Michael C., Feeney, Claire, Encinas, Gerardo A., Peeples-Lamirande, Kathleen, Cappelleri, Joseph C., Myers, Daniela E., DiBonaventura, Marco
Publicado 2021

cGMP-independent nitric oxide signaling and regulation of the cell cycle

por Cui, Xiaolin, Zhang, Jianhua, Ma, Penglin, Myers, Daniela E, Goldberg, Ilana G, Sittler, Kelly J, Barb, Jennifer J, Munson, Peter J, Cintron, Ana del Pilar, McCoy, J Philip, Wang, Shuibang, Danner, Robert L
Publicado 2005